Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Noninvasive Monitors Archives
Print | Email | Share | Comments (0)

Non-Invasive Glucose Monitoring Patch Development

Jan 1, 1994

As clearly demonstrated by the DCCT, blood glucose monitoring is a critical element in the maintenance of normal blood glucose levels. Cygnus Therapeutic Corporation in Redwood City, California is working on a new non-invasive glucose monitoring system that could dramatically change the way people with diabetes monitor their glucose levels. Unlike the current procedure, which measures the level of glucose in the blood based on blood samples drawn from the fingertips, the new system is non-invasive, and utilizes interstitial fluid rather than blood.

In a process called "reverse iontophoresis," a steady electrical current is used to extract interstitial fluid (the fluid that bathes the cells of the body) from the skin. Iontophoresis has been used for years to deliver drugs into the skin by enlarging the pores to allow large molecules (found in drugs) to enter. Reverse iontophoresis simply turns the process around, enlarging the pores to allow interstitial fluid to exit. This procedure was initially discovered by researchers at U.C.S.F. Medical School. Cygnus invested in the patent for it and is now applying it for use as a substitute to blood glucose monitoring.

Thus far, Cygnus has conducted initial testing on both animals and non-diabetic subjects with positive results. The next phase of testing, expected to commence early in 1994, will be carried out on people with diabetes. This testing will attempt to determine the accuracy of glucose measurement from interstitial fluid as compared to blood.

If the next phase of testing proves interstitial fluid to be a reliable, accurate measurement of glucose, Cygnus will begin its effort to make the process "user-friendly." The current blueprint for the product includes two components: a credit card sized "patch" that adheres to the skin; and, an equally miniaturized "power pack" for reading test results. As it is currently envisioned, the patch would remain on the skin continuously for up to 24 hours, to be replaced by a new patch each day, while the power pack would provide the "hardware" necessary to interpret the results of the chemical process. Together, the two components would allow the user to monitor the level of glucose in the interstitial fluid, both continuously and non-invasively.

Although still in the early phases of development, this research offers potential relief from the sore, callused fingertips so many of us live with as a necessary by-product of blood glucose testing, as well as the possibility of having access to continuous test results.


Categories: Blood Glucose, Diabetes, Meters, Noninvasive Monitors



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Jan 1, 1994

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.